Enanta Pharmaceuticals Stock Market Value

ENTA Stock  USD 17.46  0.93  5.63%   
Enanta Pharmaceuticals' market value is the price at which a share of Enanta Pharmaceuticals trades on a public exchange. It measures the collective expectations of Enanta Pharmaceuticals investors about its performance. Enanta Pharmaceuticals is trading at 17.46 as of the 28th of March 2024, a 5.63 percent increase since the beginning of the trading day. The stock's open price was 16.53.
With this module, you can estimate the performance of a buy and hold strategy of Enanta Pharmaceuticals and determine expected loss or profit from investing in Enanta Pharmaceuticals over a given investment horizon. Check out Enanta Pharmaceuticals Correlation, Enanta Pharmaceuticals Volatility and Enanta Pharmaceuticals Alpha and Beta module to complement your research on Enanta Pharmaceuticals.
For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.
Symbol

Enanta Pharmaceuticals Price To Book Ratio

Is Enanta Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enanta Pharmaceuticals. If investors know Enanta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enanta Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.66)
Earnings Share
(6.57)
Revenue Per Share
3.5
Quarterly Revenue Growth
(0.24)
Return On Assets
(0.23)
The market value of Enanta Pharmaceuticals is measured differently than its book value, which is the value of Enanta that is recorded on the company's balance sheet. Investors also form their own opinion of Enanta Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Enanta Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enanta Pharmaceuticals' market value can be influenced by many factors that don't directly affect Enanta Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enanta Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enanta Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enanta Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Enanta Pharmaceuticals 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Enanta Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Enanta Pharmaceuticals.
0.00
04/08/2022
No Change 0.00  0.0 
In 1 year 11 months and 22 days
03/28/2024
0.00
If you would invest  0.00  in Enanta Pharmaceuticals on April 8, 2022 and sell it all today you would earn a total of 0.00 from holding Enanta Pharmaceuticals or generate 0.0% return on investment in Enanta Pharmaceuticals over 720 days. Enanta Pharmaceuticals is related to or competes with Mustang Bio, Moleculin Biotech, Madrigal Pharmaceuticals, Equillium, Kineta, Mediwound, and YS Biopharma. Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of ... More

Enanta Pharmaceuticals Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Enanta Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Enanta Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.

Enanta Pharmaceuticals Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Enanta Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Enanta Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Enanta Pharmaceuticals historical prices to predict the future Enanta Pharmaceuticals' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Enanta Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
13.4817.4621.44
Details
Intrinsic
Valuation
LowRealHigh
14.1318.1122.09
Details
Naive
Forecast
LowNextHigh
13.4317.4121.39
Details
8 Analysts
Consensus
LowTargetHigh
25.3827.8930.96
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Enanta Pharmaceuticals. Your research has to be compared to or analyzed against Enanta Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Enanta Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Enanta Pharmaceuticals.

Enanta Pharmaceuticals Backtested Returns

Enanta Pharmaceuticals is not too volatile given 3 months investment horizon. Enanta Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.27, which denotes the company had a 0.27% return per unit of standard deviation over the last 3 months. We were able to interpolate and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.08% are justified by taking the suggested risk. Use Enanta Pharmaceuticals Downside Deviation of 2.89, semi deviation of 2.13, and Mean Deviation of 2.86 to evaluate company specific risk that cannot be diversified away. Enanta Pharmaceuticals holds a performance score of 20 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.3, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Enanta Pharmaceuticals will likely underperform. Use Enanta Pharmaceuticals sortino ratio, semi variance, and the relationship between the standard deviation and value at risk , to analyze future returns on Enanta Pharmaceuticals.

Auto-correlation

    
  0.43  

Average predictability

Enanta Pharmaceuticals has average predictability. Overlapping area represents the amount of predictability between Enanta Pharmaceuticals time series from 8th of April 2022 to 3rd of April 2023 and 3rd of April 2023 to 28th of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Enanta Pharmaceuticals price movement. The serial correlation of 0.43 indicates that just about 43.0% of current Enanta Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient0.43
Spearman Rank Test0.36
Residual Average0.0
Price Variance70.86

Enanta Pharmaceuticals lagged returns against current returns

Autocorrelation, which is Enanta Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Enanta Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Enanta Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Enanta Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Enanta Pharmaceuticals regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Enanta Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Enanta Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Enanta Pharmaceuticals stock over time.
   Current vs Lagged Prices   
       Timeline  

Enanta Pharmaceuticals Lagged Returns

When evaluating Enanta Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Enanta Pharmaceuticals stock have on its future price. Enanta Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Enanta Pharmaceuticals autocorrelation shows the relationship between Enanta Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Enanta Pharmaceuticals.
   Regressed Prices   
       Timeline  

Pair Trading with Enanta Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Enanta Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enanta Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving against Enanta Stock

  0.89KA Kineta Inc Report 29th of March 2024 PairCorr
  0.84MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.82ME 23Andme HoldingPairCorr
  0.78VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.73MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to Enanta Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Enanta Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Enanta Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Enanta Pharmaceuticals to buy it.
The correlation of Enanta Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enanta Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enanta Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Enanta Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Enanta Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enanta Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enanta Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enanta Pharmaceuticals Stock:
Check out Enanta Pharmaceuticals Correlation, Enanta Pharmaceuticals Volatility and Enanta Pharmaceuticals Alpha and Beta module to complement your research on Enanta Pharmaceuticals.
For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for Enanta Stock analysis

When running Enanta Pharmaceuticals' price analysis, check to measure Enanta Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enanta Pharmaceuticals is operating at the current time. Most of Enanta Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Enanta Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enanta Pharmaceuticals' price. Additionally, you may evaluate how the addition of Enanta Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Enanta Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Enanta Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Enanta Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...